This year’s emergence of breakthrough innovations illustrates the vitality of the health care industry. And biopharma is largely what’s underpinning this paradigm shift in the global health-care ecosystem.
The biopharma innovation flow in 2017 was the most exciting the world has seen. New modes of action emerged, and in quantity. These included cell therapy using energized T-cells to go out as foot soldiers to find and hunt down cancer cells. Gene therapy came upon the scene, this time to fix a specific gene defect in the retina of the eye.
